News
-
-
PRESS RELEASE
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. reports positive results of broad-spectrum antiviral drug NV-387 in animal models, showing sustained antiviral effect with extended flat blood concentration profile upon oral administration -
-
PRESS RELEASE
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza -
-
PRESS RELEASE
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc. elaborates on its groundbreaking host-mimetic, broad-spectrum antiviral technology platform, NV-387, designed to revolutionize viral infection treatment with advanced decoy mechanisms -
-
-
-
PRESS RELEASE
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection
-
Adam Fridman Launches Season 5 of the Future of People Initiatives Podcast: Unblock Growth
-
Contents.com Launches a Crowdfunding Campaign on Crowdcube to Accelerate Its Expansion Across Europe
-
Regional Resiliency Initiative Ensures Uninterrupted 911 Services
-
PPX Obtains Water Availability Accreditation for Beneficiation Plant
-
POPLAR CREEK RESOURCES INC. - Amended Announcement of Resignation of Auditor
-
GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
-
GEVELOT S.A.: ANNUAL GENERAL MEETING JUNE 2024 PRESS RELEASE
-
MGI – Media and Games Invest SE held its Annual General Meeting
-
Funding Circle Plc: POS-Transaction in Own Shares
-
HHLA's Annual General Meeting approves all proposed resolutions
-
Europorte and Kerlink revolutionize freight by launching Track Value, the first logistics application using Kinéis IoT space connectivity
-
AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2024
-
Declaration of voting rights at the end of May 2024
-
The Board of Directors renews Iris Knobloch as Chair of the Board of Directors
-
CDA - Acquisition of 86,5% of Urban Group